Table 3.
On Admission (N = 74) |
At Discharge (N = 64) |
p-Value | At Follow-Up (N = 55) |
p-Value | |
---|---|---|---|---|---|
IVC (cm)–mean (SD) | 2.25 (0.53) | 1.81 (0.42) | <0.001 | 1.85 (0.43) | <0.001 |
Absence of collapsibility–N (%) | 71 (95.9) | 41 (55.4) | 0.023 | 38 (51.4) | 0.321 |
Lung score–mean (SD) | 17.74 (7.23) | 6.9 (5.62) | 0.015 | 8.4 (7.8) | <0.001 |
Hepatic vein (SD) | 1.34 (0.69) | 0.98 (0.839) | <0.001 | 0.85 (0.81) | <0.001 |
S > D at hepatic vein flow–N (%) | 9 (12.2) | 20 (27) | 23 (31.1) | ||
S < D at hepatic vein flow–N (%) | 29 (39.2) | 26 (35.1) | 18 (24.3) | ||
S Reversal at hepatic vein–N (%) | 35 (47.3) | 19 (25.7) | 14 (18.9) | ||
Portal vein (SD) | 0.94 (0.839) | 0.32 (0.612) | <0.001 | 0.47 (0.56) | 0.19 |
Pulsatility < 30%–N (%) | 27 (36.5) | 50 (67.6) | 33 (44.6) | ||
Pulsatility 30–50%–N (%) | 20 (27) | 11 (14.9) | 23 (31.1) | ||
Pulsatility > 50%–N (%) | 27 (36.5) | 5 (6.8) | 2 (2.7) | ||
Intra-renal vein (SD) | 0.88 (0.734) | 0.58 (0.74) | <0.001 | 0.64 (0.76) | <0.001 |
Continuous–N (%) | 23 (31.1) | 38 (51.4) | 31 (41.9) | ||
Discontinuous Biphasic N (%) | 30 (40.5) | 18 (24.3) | 17 (23) | ||
Discontinuous monophasic–N (%) | 21 (28.4) | 10 (13.5) | 10 (13.5) | ||
VExUS score (SD) | 1.50 (1.18) | 0.65 (1.015) | <0.001 | 0.95 (1.09) | 0.052 |
VExUS 0–N (%) | 21 (28.4) | 42 (56.8) | 29 (39.2) | ||
VExUS 1–N (%) | 13 (17.6) | 12 (16.2) | 8 (10.8) | ||
VExUS 2–N (%) | 16 (21.6) | 5 (6.8) | 14 (18.9) | ||
VExUS 3 -N (%) | 24 (32.4) | 7 (9.5) | 6 (8.1) |
Abbreviations: IVC: inferior vena cava; SD: standard deviation; VExUS: venous excess ultrasonography score.